UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Effect of Mutation Order on Myeloproliferative Neoplasms

The New England journal of medicine, 2015-02, Vol.372 (7), p.601-612

2015

Volltextzugriff (PDF)

Clonal Architecture in Myeloproliferative Neoplasms: Old Dog, New Tricks?

HemaSphere, 2023-06, Vol.7 (6), p.e903-n/a

Godfrey, Anna L.

2023

Volltextzugriff (PDF)

DNMT3A mutations occur early or late in patients with myeloproliferative neoplasms and mutation order influences phenotype

Haematologica (Roma), 2015-11, Vol.100 (11), p.e438-e442

2015

Volltextzugriff (PDF)

After 10 years of JAK2V617F: Disease biology and current management strategies in polycythaemia vera

Blood reviews, 2017-05, Vol.31 (3), p.101-118

2017

Volltextzugriff (PDF)

JAK2V617F homozygosity drives a phenotypic switch in myeloproliferative neoplasms, but is insufficient to sustain disease

Blood, 2014-05, Vol.123 (20), p.3139-3151

2014

Volltextzugriff (PDF)

Low‐Risk Essential Thrombocythemia: A Comprehensive Review

HemaSphere, 2021-02, Vol.5 (2), p.e521-n/a

2021

Volltextzugriff (PDF)

Molecular diagnosis of the myeloproliferative neoplasms: UK guidelines for the detection of JAK2 V617F and other relevant mutations

British journal of haematology, 2013-01, Vol.160 (1), p.25-34

2013

Volltextzugriff (PDF)

JAK2V617F promotes replication fork stalling with disease-restricted impairment of the intra-S checkpoint response

Proceedings of the National Academy of Sciences - PNAS, 2014-10, Vol.111 (42), p.15190-15195

2014

Volltextzugriff (PDF)

RECQL5 Suppresses Oncogenic JAK2-Induced Replication Stress and Genomic Instability

Cell reports (Cambridge), 2015-12, Vol.13 (11), p.2345-2352

2015

Volltextzugriff (PDF)

Life histories of myeloproliferative neoplasms inferred from phylogenies

Nature (London), 2022-02, Vol.602 (7895), p.162-168

2022

Volltextzugriff (PDF)

Essential thrombocythemia: challenges in clinical practice and future prospects

Blood, 2023-04, Vol.141 (16), p.1943-1953

2023

Volltextzugriff (PDF)

Myeloproliferative neoplasms (MPNs)

Blood reviews, 2020-07, Vol.42, p.100717-100717, Article 100717

Godfrey, Anna L.

2020

Volltextzugriff (PDF)

Clonal analyses reveal associations of JAK2V617F homozygosity with hematologic features, age and gender in polycythemia vera and essential thrombocythemia

Haematologica (Roma), 2013-05, Vol.98 (5), p.718-721

2013

Volltextzugriff (PDF)

Genomic heterogeneity in myeloproliferative neoplasms and applications to clinical practice

Blood reviews, 2020-07, Vol.42, p.100708-100708, Article 100708

2020

Volltextzugriff (PDF)

STAT1 activation in association with JAK2 exon 12 mutations

Haematologica (Roma), 2016-01, Vol.101 (1), p.e15-e19

2016

Volltextzugriff (PDF)

Clinical utility of investigations in triple‐negative thrombocytosis: A real‐world, multicentre evaluation of UK practice

British journal of haematology, 2024-10, Vol.205 (4), p.1411-1416

2024

Volltextzugriff (PDF)

Hydroxycarbamide Plus Aspirin Versus Aspirin Alone in Patients With Essential Thrombocythemia Age 40 to 59 Years Without High-Risk Features

Journal of clinical oncology, 2018-12, Vol.36 (34), p.3361-3369

2018

Volltextzugriff (PDF)

Continuous Indexing of Fibrosis (CIF): improving the assessment and classification of MPN patients

Leukemia, 2023-02, Vol.37 (2), p.348-358

2023

Volltextzugriff (PDF)

Inherited polygenic effects on common hematological traits influence clonal selection on JAK2V617F and the development of myeloproliferative neoplasms

Nature genetics, 2024-02, Vol.56 (2), p.273-280

2024

Volltextzugriff (PDF)

Genotype-Phenotype Interactions in the Myeloproliferative Neoplasms

Hematology/oncology clinics of North America, 2012-10, Vol.26 (5), p.993-1015

2012

Volltextzugriff (PDF)

Driver Mutation Acquisition in Utero and Childhood Followed By Lifelong Clonal Evolution Underlie Myeloproliferative Neoplasms

Blood, 2020-11, Vol.136 (Supplement_2), p.LBA-1-LBA-1

2020

Volltextzugriff (PDF)

Changes in practice within a haematological malignancy diagnostic service: A 5‐year retrospective study

British journal of haematology, 2024-07, Vol.205 (1), p.378-381

2024

Volltextzugriff (PDF)

Clonal hematopoiesis and therapy-related myeloid neoplasms following neuroblastoma treatment

Blood, 2021-05, Vol.137 (21), p.2992-2997

2021

Volltextzugriff (PDF)

Diagnosis and evaluation of prognosis of myelofibrosis: A British Society for Haematology Guideline

British journal of haematology, 2024-01, Vol.204 (1), p.127-135

2024

Volltextzugriff (PDF)

1 – 25 von 155

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(150)
Mit Volltextzugriff
(132)

Publikationsform

Sprache

Englisch
(155)

Erscheinungsjahr

n.n

Thema

Science & Technology
(122)
Life Sciences & Biomedicine
(109)
Humans
(95)
Male
(40)
Female
(34)
Hematology
(31)
Middle Aged
(25)
Adult
(22)
Janus Kinase 2 - Genetics
(22)
Mutation
(21)
Aged
(20)
Infectious Diseases
(20)
Medicin Och Hälsovetenskap
(18)
Animals
(14)
General & Internal Medicine
(14)
Medicine, General & Internal
(14)
Oncology
(14)
Myeloproliferative Disorders - Genetics
(13)
Child
(12)
Genomes
(12)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Effect of Mutation Order on Myeloproliferative Neoplasms

Clonal Architecture in Myeloproliferative Neoplasms: Old Dog, New Tricks?

DNMT3A mutations occur early or late in patients with myeloproliferative neoplasms and mutation order influences phenotype

After 10 years of JAK2V617F: Disease biology and current management strategies in polycythaemia vera

JAK2V617F homozygosity drives a phenotypic switch in myeloproliferative neoplasms, but is insufficient to sustain disease

Low‐Risk Essential Thrombocythemia: A Comprehensive Review

Molecular diagnosis of the myeloproliferative neoplasms: UK guidelines for the detection of JAK2 V617F and other relevant mutations

JAK2V617F promotes replication fork stalling with disease-restricted impairment of the intra-S checkpoint response

RECQL5 Suppresses Oncogenic JAK2-Induced Replication Stress and Genomic Instability

Life histories of myeloproliferative neoplasms inferred from phylogenies

Essential thrombocythemia: challenges in clinical practice and future prospects

Myeloproliferative neoplasms (MPNs)

Clonal analyses reveal associations of JAK2V617F homozygosity with hematologic features, age and gender in polycythemia vera and essential thrombocythemia

Genomic heterogeneity in myeloproliferative neoplasms and applications to clinical practice

STAT1 activation in association with JAK2 exon 12 mutations

Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms

Clinical utility of investigations in triple‐negative thrombocytosis: A real‐world, multicentre evaluation of UK practice

Hydroxycarbamide Plus Aspirin Versus Aspirin Alone in Patients With Essential Thrombocythemia Age 40 to 59 Years Without High-Risk Features

Continuous Indexing of Fibrosis (CIF): improving the assessment and classification of MPN patients

Inherited polygenic effects on common hematological traits influence clonal selection on JAK2V617F and the development of myeloproliferative neoplasms

Genotype-Phenotype Interactions in the Myeloproliferative Neoplasms

Driver Mutation Acquisition in Utero and Childhood Followed By Lifelong Clonal Evolution Underlie Myeloproliferative Neoplasms

Changes in practice within a haematological malignancy diagnostic service: A 5‐year retrospective study

Clonal hematopoiesis and therapy-related myeloid neoplasms following neuroblastoma treatment

Diagnosis and evaluation of prognosis of myelofibrosis: A British Society for Haematology Guideline

Suchergebnisse filtern